Boston Scientific Corp
BSX
$104.32+0.69 (+0.67%)
Jul 5, 2025, 4:00 PM
Financials
| 52Week High | 107.53 | 52Week Low | 71.88 |
| Beta | 0.66 | Current Ratio Annual | 1.08 |
| Current Ratio Quarterly | 1.45 | Gross Margin TTM | 68.65 |
| Market Cap | 154.34B | Net Profit Margin TTM | 11.58 |
| Operating Margin TTM | 16.23 | Price To Book | 6.95 |
| Price To Earnings TTM | 75.92 | Price To Free Cash Flow TTM | 51.21 |
| Price To Sales TTM | 8.79 | Quick Ratio Annual | 0.59 |
| Quick Ratio Quarterly | 0.83 | Return On Assets TTM | 5.26 |
| Return On Equity TTM | 9.56 | Return On Investment TTM | 6.32 |
| Revenue Growth3Y | 12.10 | Revenue Growth5Y | 9.30 |
| Revenue Growth Quarterly Yoy | 20.93 | Revenue Growth TTMYoy | 19.35 |
| Revenue Per Share TTM | 11.76 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1554 | 200 | 131 | 628 | 525 | 174 | 1.33B | $126.49B |
| Jun 30, 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $0 |
| Change | 1.55K(100%) | 200(100%) | 131(100%) | 628(100%) | 525(100%) | 174(100%) | 1.33B(100%) | $126.49B(100%) |